EXT1-SAMD12 Fusion FISH Probe
The EXT1-SAMD12 Fusion FISH Probe is used to confirm a fusion of the EXT1 and SAMD12 genes. The fusion of the EXT1 and SAMD12 genes has been associated with Breast Invasive Carcinoma, Head And Neck Squamous Cell Carcinoma , Prostate Adenocarcinoma, Pancreatic Adenocarcinoma, Sarcoma, Lung Squamous Cell Carcinoma, and Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| EXT1-SAMD12-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-RERE | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-REOR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-REGO | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-REGR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-OROR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GORE | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GROR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| EXT1-SAMD12-20-AQAQ | 20 (40 μL) | 200 μL |
|
EXT1 Gene Summary
This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008]
Gene Name: Exostosin Glycosyltransferase 1
Chromosome: CHR8: 118811601 -119124058
Locus: 8q24.11
SAMD12 Gene Summary
The Sterile Alpha Motif Domain Containing 12 (SAMD12) gene is located on chr8 :119201694-119634184 at 8q24.11-q24.12.
Gene Name: Sterile Alpha Motif Domain Containing 12
Chromosome: CHR8: 119201694 -119634184
Locus: 8q24.11-q24.12
Gene Diseases
The EXT1 SAMD12 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Head And Neck Squamous Cell Carcinoma |
| Prostate Adenocarcinoma |
| Pancreatic Adenocarcinoma |
| Sarcoma |
| Lung Squamous Cell Carcinoma |
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|